Yuan Yuan

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Dna Methylation

Small Cell Lung Cancer

Top Venues

Cancer immunology, immunotherapy : CII

Breast cancer research : BCR

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Rainone, Saro Kasparian, Tina Nguyen, Neel Talwar, Yuan Yuan, Matthew Mei, Joanne E Mortimer, James R Waisman, Niki Patel, Vinod A Pullarkat
Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates. The oncologist (2023)
Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Joanne L Blum, Lida A Mina, Raymond Brig, Michael Danso, Yuan Yuan, Antonello Abbattista, Kay Noonan, Alexander Niyazov, Jayeta Chakrabarti, Akos Czibere, William F Symmans, Melinda L Telli
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study. The oncologist (2023)
Yuan Yuan, Susan E Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang, Norma Martinez, Daniel Schmolze, James Waisman, Niki Patel, Lalit Vora, Lusine Tumyan, Mari Bozoghlanian, Daphne Stewart, Paul H Frankel
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer. The oncologist (2023)
Colt A Egelston, Weihua Guo, Susan E Yost, Xuan Ge, Jin Sun Lee, Paul H Frankel, Yujie Cui, Christopher Ruel, Daniel Schmolze, Mireya Murga, Aileen Tang, Norma Martinez, Misagh Karimi, George Somlo, Peter P Lee, James R Waisman, Yuan Yuan
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer. Cancer immunology, immunotherapy : CII (2023)
Francesca Menghi, Kalyan Banda, Pooja Kumar, Robert Straub, Lacey Elizabeth Dobrolecki, Isabel V Rodriguez, Susan E Yost, Harshpreet Chandok, Marc R Radke, George Somlo, Yuan Yuan, Michael T Lewis, Elizabeth M Swisher, Edison T Liu
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas. Science translational medicine 14 (652) (2022)
Kyung-Min Lee, Chang-Ching Lin, Alberto Servetto, Joonbeom Bae, Vishal Kandagatla, Dan Ye, Gun Min Kim, Dhivya R Sudhan, Saurabh Mendiratta, Paula I Gonzalez Ericsson, Justin M Balko, Jeon Lee, Spencer Barnes, Venkat S Malladi, Siamak Tabrizi, Sangeetha M Reddy, Seoyun Yum, Ching-Wei Chang, Katherine E Hutchinson, Susan E Yost, Yuan Yuan, Zhijian J Chen, Yang-Xin Fu, Ariella B Hanker, Carlos L Arteaga
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer. Cancer immunology research 10 (7) (2022)
Siqing Fu, Shuyang Yao, Yuan Yuan, Rebecca Ann Previs, Anthony D Elias, Richard D Carvajal, Thomas J George, Ying Yuan, Lihou Yu, Shannon Neville Westin, Yan Xing, Ecaterina E Ileana Dumbrava, Daniel D Karp, Sarina A Piha-Paul, Apostolia-Maria Tsimberidou, Jordi Rodon Ahnert, Naoko Takebe, Karen H Lu, Khandan Keyomarsi, Funda Meric-Bernstam
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Karen L Reckamp, Jasmine A McQuerry, Isa Mambetsariev, Rebecca R Pharaon, Susan E Yost, Jeremy Fricke, Tamara Mirzapoiazova, Raju K Pillai, Ziad Khan, Marwan G Fakih, Yuan Yuan, Marianna Koczywas, Erminia Massarelli, Prakash Kulkarni, Sumanta Kumar Pal, Martin Sattler, Andrea Bild, Ravi Salgia
Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations. Future science OA 7 (2) (2020)
Yuan Yuan, Jin Sun Lee, Susan E Yost, Paul H Frankel, Christopher Ruel, Colt A Egelston, Weihua Guo, John D Gillece, Megan Folkerts, Lauren Reining, Sarah K Highlander, Kim Robinson, Simran Padam, Norma Martinez, Aileen Tang, Daniel Schmolze, James Waisman, Mina Sedrak, Peter P Lee, Joanne Mortimer
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer. The oncologist 26 (2) (2020)
Ting-Fang He, Susan E Yost, Paul H Frankel, Andrew Dagis, Yu Cao, Roger Wang, Anthony Rosario, Travis Yiwey Tu, Shawn Solomon, Daniel Schmolze, Joanne Mortimer, Peter Lee, Yuan Yuan
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis. PloS one 15 (3) (2020)
Jin Sun Lee, Susan E Yost, Suzette Blanchard, Daniel Schmolze, Hongwei Holly Yin, Raju Pillai, Kim Robinson, Aileen Tang, Norma Martinez, Jana Portnow, Wei Wen, John H Yim, Heather Ann Brauer, Yuqi Ren, Thehang Luu, Joanne Mortimer, Yuan Yuan
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer. Breast cancer research : BCR 21 (1) (2019)